Department of Pediatrics
Wendy Darlington is a pediatric hematologist/oncologist whose primary research focuses on examining the health outcomes of patients with sickle cell disease. Clinically she is interested in caring for both benign and malignant hematologic disorders of childhood as well as pediatric brain tumors. Using sickle cell disease as a model for chronic childhood illness, her current research focuses on understanding the complex interaction between health outcomes and socioeconomic indicators. She is currently looking at how public policies intended to increase access and appropriate health care utilization are changing patient outcomes.
Darlington graduated with an MD from the University of Texas Medical Branch at Galveston. She completed her pediatrics residency at Children’s Medical Center Dallas/The University of Texas Southwestern Medical Center, as well as a pediatric hematology/oncology fellowship at the University of Chicago. In addition, she earned a master of arts degree in public policy from the University of Chicago Harris School of Public Policy. She is a founding member of the Chicago Sickle Cell Disease Research Group.